MAPT and Alzheimer disease: Furthermore, in the follow-up experiment, the delivery of IL-4 was proven to improve cognitive performance and alleviate tau pathology by increasing arginase-1 positive microglia cells in the 3xTg AD mice (Figure 3) (110).